Choosing a HealthTech lead generation agency requires more than comparing meeting targets and monthly fees. You need a partner that understands your target market, can engage the right stakeholders and has a clear process for qualifying conversations and measuring pipeline progression.
HealthTech sales can involve clinical, technical, operational, compliance and commercial stakeholders, each with different priorities. A conversation that starts positively may still fail to progress if the wider buying team cannot establish the value, manage the risks or agree on the next step.
When comparing healthcare lead generation companies, look beyond what they promise to deliver. Evaluate how they select accounts, engage buying committees, qualify opportunities, handle data and product claims, and report on pipeline performance.
This guide provides a practical framework for comparing providers and deciding whether an external partner is the right fit for your sales process.
What should a HealthTech company look for in a lead generation partner?
A HealthTech company should look for relevant market experience, a structured approach to account selection, buying committee coverage, clear qualification criteria, appropriate compliance processes and reporting that goes beyond activity counts.
The following scorecard provides a starting point for evaluating providers consistently.
Evaluation criterion | Suggested weighting | What good evidence looks like | Warning sign |
Market and account selection | 20% | A documented approach to segmentation, account scoring and prioritisation. | A purchased list with no clear logic behind account selection |
Healthcare experience | 15% | Relevant client examples, references and an explanation of how the provider understands your segment | Broad claims of healthcare expertise without supporting examples |
Buying committee coverage | 15% | Role-based outreach and reporting on stakeholder engagement across accounts | Treating one contact as the entire buying decision |
Qualification and progression | 20% | Written qualification criteria, clear handover requirements and meeting-to-opportunity tracking | Success measured primarily by meetings booked |
Compliance and claim discipline | 15% | Documented data-handling procedures, approved messaging and a clear escalation process | Vague assurances or unsupported clinical and regulatory claims |
Reporting and optimisation | 15% | Visibility into account engagement, conversion and pipeline progression | Activity reports that do not show what happens afterwards |
The weightings are suggested priorities rather than an industry-wide benchmark. Adapt them to your product, sales process and commercial objectives.
To compare providers, rate each criterion from 1 to 5 based on the evidence supplied. Multiply each rating by its weighting, then divide by five to calculate the weighted score. Add the results to obtain a score out of 100.
Use the score to guide discussion rather than make the decision automatically. A high overall rating should not compensate for a serious gap in data handling, qualification quality or accountability.
Why are generic B2B evaluation criteria insufficient for HealthTech?
Metrics such as cost per meeting, email response rates, and outreach volume can help assess an outbound programme, but they do not establish whether the programme is creating opportunities your sales team can progress.
HealthTech purchases may involve clinical leadership, IT, security, compliance, finance, procurement and executive sponsors. The precise combination depends on the product and organisation, and each stakeholder may assess the purchase against different requirements.
A provider that focuses on generating interest from one contact without considering the wider buying process may produce meetings that never advance.
The regulated environment also calls for careful handling of data and product claims. A generalist provider should be able to explain how its processes adapt to your market rather than assuming that the same outreach approach works everywhere.
How should a partner approach market and account selection?
Before outreach begins, your partner should explain which organisations it intends to target and why.
HealthTech buyers differ widely. Health systems, healthcare providers, payers and life sciences organisations have different structures, priorities and purchasing processes. Even within one segment, your ideal accounts will depend on the problem your product solves and the conditions required for adoption.
Ask the provider how it defines your ideal customer profile (ICP), prioritises accounts and identifies relevant buying signals. It should be able to explain why an organisation qualifies as a target rather than relying on broad industry categories or job titles alone.
You should also agree on how the account list will be reviewed. Your internal team may know about existing relationships, active opportunities, unsuitable accounts or strategic priorities that should influence targeting.
A structured selection process helps you understand where outreach effort is going and why certain accounts are being prioritised.
How should a partner cover the buying committee?
A partner should plan engagement around the relevant stakeholders within an account, not just the number of individual contacts generated.
Depending on your product, this may involve clinical leadership, IT, security, compliance, operations, procurement, finance or executive sponsors. These stakeholders are not interchangeable, and a single message may not address their different concerns.
Ask which roles the provider would target in your segment, how messaging would vary by stakeholder and how engagement across the account would be reported.
A useful test is whether the provider can show, from a relevant past programme, how many stakeholders were engaged within target accounts and what happened next.
The objective is not to contact as many people as possible. It is to build a clearer understanding of the account, engage the people who influence the decision and establish whether there is a credible path towards a buying decision.
What do qualification and progression evidence look like?
Qualification determines when a booked conversation becomes a credible sales opportunity and what information your sales team needs to act on it.
Before launching a programme, agree on the criteria a meeting must meet to be passed to sales. These might include fit with your ICP, a relevant business problem, an appropriate stakeholder, a reason to explore the solution and a clear next step.
The criteria will depend on your objectives. A company testing a new segment may initially prioritise learning about buyer needs, while a team targeting established enterprise accounts may require stronger evidence of commercial need and buying readiness.
Ask the provider for its written qualification criteria, who approves them and how the information is recorded at handover. You should also establish how meetings that fall short of the agreed criteria will be handled.
Crucially, ask how the provider tracks what happens after handover. If measurement stops at the meeting, it cannot show whether conversations are becoming opportunities or where the programme may need improvement.
How should compliance awareness and claim discipline be assessed?
HealthTech companies should understand how a prospective provider handles data and ensures outreach stays within approved messaging.
The requirements that apply depend on the data involved, the organisations and people concerned, the jurisdictions in scope and the nature of the product.
When evaluating a provider, ask practical questions:
- What prospect information will be collected, stored and used during outreach?
- Who can access that information, and which systems will hold it?
- How are messaging and product claims reviewed and approved?
- What happens if a prospect shares sensitive information that the SDR does not need?
- Who handles compliance questions, and when are they escalated to your team?
- What data and records will remain accessible to you after the engagement ends?
Claim discipline also matters. Outreach should not imply that a product has regulatory authorisation, clinical evidence or capabilities beyond what your organisation has approved and can substantiate.
A provider that can explain its procedures and responsibilities gives you a clearer basis for evaluation than one that offers only general assurances.
What reporting and pipeline measurement should you expect?
Reporting should help you understand whether the programme is generating relevant engagement and creating opportunities that can progress.
Before launch, agree on the definitions of each metric, reporting frequency and responsibility for maintaining the data.
Depending on your objectives, useful measures may include:
- Target accounts engaged: The number and proportion of target accounts reached, with context on account fit and response.
- Stakeholder coverage: The relevant roles engaged within target accounts.
- Qualified meetings: Meetings that meet the criteria agreed before launch.
- Meeting-to-opportunity conversion: The proportion of qualified meetings that become recognised sales opportunities.
- Pipeline created: The value of opportunities attributed to the programme under an agreed attribution method.
- Progression and outcomes: What happens after handover, including stalled opportunities and closed outcomes where data is available.
No single metric tells the whole story. Meeting volume can show whether outreach is generating conversations, while conversion and progression measures help reveal whether those conversations are commercially useful.
You should also agree on access to relevant CRM records, how sales feedback will be captured, and what happens to programme data when the engagement ends.
The objective is to create a shared view of performance that helps both teams make better decisions.
What questions should you ask providers before selecting one?
Use these questions when evaluating a healthcare lead generation company. Request supporting evidence wherever possible.
- Which healthcare or comparable technology markets have you worked in? Ask for examples relevant to your product, buyer roles and sales process.
- How do you choose and score accounts in our segment? Look for a clear methodology rather than a generic contact list.
- Which stakeholders would you engage within our target accounts? Ask how outreach would vary by role and how coverage would be reported.
- What are your written qualification criteria? Establish who agrees on the criteria and what information sales will receive at handover.
- How do you track meetings through to opportunities? Ask how the provider measures opportunity creation, progression and feedback.
- How do you handle data and compliance questions? Request a documented explanation of data handling, responsibilities and escalation routes.
- How do you keep messaging within our approved claims? Confirm how content is reviewed and changes are authorised.
- What reporting will we receive, and what data will we own? Agree on reporting frequency, CRM visibility, access and arrangements at the end of the engagement.
- What would make you advise us not to proceed? A provider should be able to identify situations where the proposition, targeting, internal sales process or commercial expectations need attention first.
Compare providers using the same questions. Specific examples, clear responsibilities and an honest discussion of limitations are more useful than broad promises about results.
When is an outsourced partner a good fit, and when is it not?
Outsourced support is most useful when it addresses a defined gap in your pipeline generation process.
Scenario | Likely fit | Reason |
You have a validated ICP, a clear proposition and a sales team ready to handle qualified meetings | Strong | The partner can focus on reaching relevant buyers and creating opportunities. |
You are entering a new segment or region and need additional outbound capacity | Potentially strong | External support can help test targeting and messaging with agreed success measures. |
Your proposition or regulatory position remains unclear | Poor for immediate scaling | More outreach is unlikely to resolve foundational product, positioning or approval issues. |
Your target market is small and existing relationships already cover most relevant accounts | Depends | An internal approach may offer better control when broad outbound activity is unnecessary. |
Your team has no clear process for accepting and progressing qualified meetings | Not yet ready | Ownership, follow-up and opportunity management should be established before adding more conversations. |
The right decision depends on your readiness, not simply on whether you have the budget to hire an agency.
A capable provider should help establish what needs to be in place, what outcomes are realistic and how performance will be evaluated before the programme begins.
How does The Point Company approach HealthTech pipeline generation?
The Point Company’s HealthTech offering describes a pipeline generation model that combines SDRs, process, data, technology and AI to help HealthTech companies target suitable accounts, qualify conversations and improve visibility into progression.
These are useful areas to examine when assessing whether a provider’s operating model matches your own sales process. Ask how account selection, stakeholder engagement, qualification and reporting would be applied to your ICP and commercial objectives.
You can also explore The Point Company’s services for an overview of its wider pipeline generation capabilities, or review our Armis case study for an example of its work in the cybersecurity market.
The best partnership will ultimately be one that fits your target market, internal sales capacity and commercial objectives, with clear expectations on both sides.
FAQ
Does a HealthTech SDR partner need healthcare-specific experience?
Healthcare-specific experience is beneficial, but it is not the only way to establish credibility. Experience in an adjacent regulated or complex technology market may be relevant if the provider can demonstrate how it applies to your buyers, sales process and requirements.
How should healthcare lead generation companies be compared?
Use the same evaluation criteria for every provider. Compare account selection, relevant experience, buying committee coverage, qualification, compliance processes, claim discipline and reporting. Score the responses against written criteria and request evidence rather than relying on sales presentations alone.
What is the difference between lead generation and sales development in healthcare?
Lead generation is the broader process of creating interest and potential sales opportunities. Sales development typically focuses on prospecting, engaging relevant buyers and qualifying conversations before handing them to the sales team. Providers may use these terms differently, so confirm the actual scope of their services.
Should a provider guarantee meetings?
A meeting guarantee is only meaningful when the contract defines what counts as a qualifying meeting, how quality is assessed and what happens when agreed delivery standards are not met. Evaluate any guarantee alongside qualification criteria, sales acceptance, opportunity progression and reporting.
When should a HealthTech company avoid outsourcing lead generation?
Outsourcing may be premature when the product proposition is unclear, the target market has not been defined, messaging has not received the necessary approvals, or the sales team has no process for following up qualified conversations. Addressing these gaps first gives a future programme a clearer basis for success.
Conclusion
Choosing a HealthTech lead generation agency requires more than comparing meeting volumes and prices. The stronger decision comes from understanding how each provider approaches your market, engages the people involved in buying decisions, qualifies opportunities and measures what happens after a conversation.
Use a consistent scorecard, ask for supporting evidence and agree on qualification, compliance responsibilities and reporting before signing a contract. Most importantly, choose a partner whose process fits your commercial objectives and whose definition of success extends beyond filling the calendar.
To explore how The Point Company approaches HealthTech pipeline generation, visit the HealthTech offering.